4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2014 / Repeated measures crossover dietary intervention
In a repeated measures crossover study, young male smokers consumed 250 g/day of broccoli for 10 days. Broccoli intake significantly increased plasma levels of folate (+17%) and lutein (+39%), while no significant effect was observed for TNF-α, IL-6, IL-6sR, or adiponectin. Plasma CRP decreased by 48% (post-hoc analysis, p < 0.05) following the broccoli diet, independently of lutein and folate changes.
Riso P, Vendrame S, Del Bo' C, et al. Int J Food Sci Nutr, 2014. PMID 23992556
2014 / Clinical trial
Twenty-nine human subjects underwent an initial intranasal diesel exhaust particle challenge to assess inflammatory response. After a four-week washout, participants ingested broccoli sprout extract supplying 100 μmol sulforaphane daily for four days before undergoing a repeat particle challenge. Pretreatment with the extract decreased total cell counts in nasal lavage fluid by 54% (p < 0.001).
Heber D, Li Z, Garcia-Lloret M, et al. Food Funct, 2014. PMID 24287881
2014 / Randomized, double-blind, placebo-controlled trial
Healthy young adult smokers and nonsmokers ingested broccoli sprout homogenate or alfalfa placebo for four days, receiving live attenuated influenza virus intranasally on the second day. In smokers, broccoli sprout ingestion significantly lowered post-inoculation nasal lavage IL-6 responses (P = 0.03) and influenza sequence quantity (P = 0.01), while raising quinone oxidoreductase. In nonsmokers, a similar downward trend in viral quantity did not achieve statistical significance.
Noah TL, Zhang H, Zhou H, et al. PLoS One, 2014. PMID 24910991
2014 / Randomized controlled trial
In a 12-week randomized trial of 291 adults in China, drinking a daily broccoli sprout beverage significantly increased urinary excretion of glutathione conjugates of benzene by 61% and acrolein by 23% compared with placebo (P <= 0.01). Excretion of crotonaldehyde conjugates remained unchanged. Urinary sulforaphane metabolites showed that bioavailability was sustained throughout the 12-week daily dosing regimen.
Egner PA, Chen JG, Zarth AT, et al. Cancer Prev Res (Phila), 2014. PMID 24913818
2009 / Placebo-controlled dose escalation trial
A placebo-controlled dose escalation trial evaluated oral sulforaphane from a standardized broccoli sprout homogenate in human subjects. Dosing safely produced dose-dependent increases in upper airway nasal lavage cell RNA expression for GSTM1, GSTP1, NQO1, and HO-1, peaking at the 200 g sprout dose. In contrast, ingestion of control alfalfa sprouts lacking sulforaphane failed to stimulate Phase II enzyme induction.
Riedl MA, Saxon A, Diaz-Sanchez D Clin Immunol, 2009. PMID 19028145
2016 / Case-control study
A case-control study in China evaluated diet and risk factors among 600 women with uterine fibroids and 600 controls. Multifactor analysis showed that women with uterine fibroids reported less frequent intake of broccoli (OR: 0.552; 95% CI: 0.316-0.964), cabbage (OR: 0.446; 95% CI: 0.211-0.943), Chinese cabbage (OR: 0.311; 95% CI: 0.102-0.946), tomato (OR: 0.453; 95% CI: 0.241-0.853), and apple (OR: 0.416; 95% CI: 0.213-0.814) (all P < 0.05).
Shows an association, not proof of cause and effect.
Shen Y, Wu Y, Lu Q, et al. J Obstet Gynaecol Res, 2016. PMID 26458740